Belgium

  • 20 Oct 2006

Drug company UCB's acquisition facility via BNP Paribas and Fortis Bank will be launched next week.

The loan will back its Eu4.4bn takeover of German rival Schwarz Pharma. The deal will be fully underwritten by the two bookrunners.

UCB's cash and share offer amounts to Eu50 in cash per Schwarz ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 Bank of America Merrill Lynch (BAML) 1,284 2 30.09
2 Barclays 633 1 14.82
3 BNP Paribas 509 1 11.91
4 Citi 467 1 10.94
5 Morgan Stanley 455 1 10.66

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 10,064.23 34 12.48%
2 Barclays 7,915.37 23 9.82%
3 Bank of America Merrill Lynch 7,473.95 24 9.27%
4 JPMorgan 7,314.30 26 9.07%
5 Wells Fargo Securities 6,484.83 25 8.04%